- Home
- PHAR vs TEN Comparison
PHAR vs TEN Comparison
Compare PHAR & TEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- TEN
- Stock Information
- Founded
- PHAR 1988
- TEN 1993
- Country
- PHAR Netherlands
- TEN Greece
- Employees
- PHAR N/A
- TEN N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- TEN
- Sector
- PHAR Health Care
- TEN
- Exchange
- PHAR Nasdaq
- TEN NYSE
- Market Cap
- PHAR 731.1M
- TEN 595.6M
- IPO Year
- PHAR N/A
- TEN N/A
- Fundamental
- Price
- PHAR $10.00
- TEN $20.74
- Analyst Decision
- PHAR Strong Buy
- TEN Buy
- Analyst Count
- PHAR 3
- TEN 2
- Target Price
- PHAR $30.00
- TEN $30.50
- AVG Volume (30 Days)
- PHAR 3.6K
- TEN 470.2K
- Earning Date
- PHAR 07-31-2025
- TEN 06-17-2025
- Dividend Yield
- PHAR N/A
- TEN 7.35%
- EPS Growth
- PHAR N/A
- TEN N/A
- EPS
- PHAR N/A
- TEN 4.46
- Revenue
- PHAR $320,708,000.00
- TEN $799,523,000.00
- Revenue This Year
- PHAR $13.31
- TEN N/A
- Revenue Next Year
- PHAR $7.68
- TEN $9.46
- P/E Ratio
- PHAR N/A
- TEN $4.66
- Revenue Growth
- PHAR 24.13
- TEN N/A
- 52 Week Low
- PHAR $6.65
- TEN $13.40
- 52 Week High
- PHAR $12.61
- TEN $28.19
- Technical
- Relative Strength Index (RSI)
- PHAR 43.61
- TEN 60.41
- Support Level
- PHAR $9.99
- TEN $20.08
- Resistance Level
- PHAR $10.59
- TEN $20.84
- Average True Range (ATR)
- PHAR 0.35
- TEN 0.65
- MACD
- PHAR -0.14
- TEN -0.01
- Stochastic Oscillator
- PHAR 7.45
- TEN 72.69
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About TEN TSAKOS ENERGY NAVIGATION
Tsakos Energy Navigation Ltd is a seaborne transportation service provider for crude oil and petroleum products. The company's carriers cater to national and international independent oil companies and refiners. It generates revenue through charter contracts with its clients, which include time, bareboat, and voyage charters, contracts of affreightment, and pool arrangements.